About Us

OUR

Story

We as patients observed the underpenetration of online reservation procedures in Japan market and the prevalence of traditional process of calling medical institutes to secure appointment with the doctors in country like Japan which is seen as one of the most technologically advanced country in the world. This further worsens the situation for non-Japanese speakers to access the healthcare.

As Pharma marketing consultants, we realized challenges companies are facing to drive their digital transformation initiatives with the existing digital marketing agencies.

Japan being the second largest pharma market in the world, the adoption of digital technology is still underpenetrated. These opportunity areas inspired us to focus on delivering impact to all the stakeholders while contributing to advancing the digital transformation in Japan healthcare market.

OUR

Capabilities

Deep understanding of pharma business

We have worked with 25+ healthcare companies for the past 9 years and understand the dynamics of marketing in the healthcare industry.

Our experience is spread across working with leadership team of several functions – commercial excellence, IT, Omnichannel marketing, strategy, etc.

Niche skillset – Omnichannel marketing, AI/ML applications, and data strategy

We are uniquely positioned with the niche skillset compared to our competitors.

We have expertise in omnichannel marketing and AI/ML adoption, which are the two big strategic investment areas for pharma companies in Japan.

Innovation and flexible mindset to bring advanced features

We will continue to provide superior experience to our customers by exploring new capabilities, new technologies and new solutions.

We will aspire to deliver tangible values, which our customers can experience and feel the impact.

Revolutionizing Healthcare in Japan

Smart Digital Platforms Enhancing Patient, Doctor, and Life Sciences Technology Experiences

LET'S CONNECT

PROFILE

Who we are

Kota Ando

CO-Founder and CEO

Andy has worked with multiple pharma companies in Japan over last 4+ years solving several sales and marketing business issues. He is passionate about solving real world problems make an one platform and bring efficiency in the live of all stake holders.

Manjunatha Chandrappa

Co-Founder and CAIO

Manju has worked in multiple life sciences companies in Japan, US and European markets over last 8+ years shaping omnichannel capabilities and driving digital transformation initiatives in his previous consulting career. He is excited to bring impactful digital health solutions to Japan healthcare market.

Dr. So Ishii (Medical Doctor)

MEDICAL ADVISOR

Dr. Ishii is an esteemed cardiologist with 18+ years of experience working with a community hospital, a reputed global pharmaceutical company (Lilly Japan), and currently practicing at his clinic Kudanshita Eki-mae CoCo Clinic, to accelerate his practice in disease prevention.

He graduated from the Nippon Medical School, Faculty of Medicine. After residency training in internal medicine and cardiology at the National Hospital Organisation Tokyo Medical Centre, he decided to make the prevention of cardiovascular events his lifework and completed his postgraduate studies at the Institute of Geriatric Diseases, Nippon Medical School, where he was engaged in basic research on atherosclerosis, endocrinology and metabolism. Completed graduate studies in the Department of Bioregulation in the Graduate School of Nippon Medical School.

Dr.Ishii will work closely with our leadership team to help develop strategies and guide our company to develop relevant and useful solutions for Japan healthcare market.

Haoyu Wang

CUSTOMER SUCCESS DIRECTOR

Holds a Master’s degree in Physical Engineering from the University of Tokyo. At ZS Associates, he supported executive teams at more than 20 pharmaceutical and medical device companies in Japan and globally, including some of the largest in the world. Using a wide range of approaches, including workshop design and data analysis, he helped develop go-to-market strategies for new products.